Model N to Present Global Pricing and Tendering Strategies

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
209
Model N to Present Global Pricing and Tendering Strategies at Pharma Pricing and Market Access Congress 2017

REDWOOD CITY, CA --(Marketwired - February 22, 2017) - Model N, Inc. ( NYSE : MODN ), the leading provider of cloud-based revenue management solutions to life sciences, high tech and manufacturing companies, today announced its bronze sponsorship for the Pharma Pricing and Market Access Congress 2017. The Congress is being held February 22-23, 2017, at the Victoria Park Plaza in London, UK.

Model N brings deep thought leadership and industry expertise and a top-tier pharmaceutical customer roster including Johnson & Johnson, AstraZeneca, Novartis and others. During the conference, Model N will share industry trends and best practices that are shaping selling and pricing in the pharmaceutical industry. In addition, Model N will be at booth #12 to showcase how its Global Pricing Management solution and Global Tender Management solution drive better price decisions and price execution.

"The pharmaceutical industry is going through a transition, with global pricing taking center stage," said Marc Baumgartner, senior vice president and general manager of life sciences at Model N. "Simultaneously, negotiations for prices in different countries are getting more complex. For pharma manufacturers to achieve true global pricing excellence, they need a pricing strategy that anticipates regulatory entanglements and plans for the global impact of country-level price changes."

Failing to manage and understand pricing and tendering processes can translate into revenue loss amounting to tens of millions of dollars. Model N's solutions help global pharmaceutical companies maximize revenues by reducing the risk of price erosion and maintaining compliance.

During the conference, Model N will present alongside customer AstraZeneca, represented by Global Pricing Implementation Director Claire Boskamp, on how life sciences companies can effectively manage and understand pricing on a global level.

Please join Model N and AstraZeneca on Wednesday, February 22, 2017, at 2:10 p.m. CET for a presentation on "Global Pricing and Tender Management: How Can I Optimize My Commercial Strategy?" or stop by booth #12 for more information.

About Model N Model N is the leader in Revenue Management solutions. Driving mission critical business processes such as configure, price and quote (CPQ), contract and rebate management, business intelligence, and regulatory compliance, Model N solutions transform the revenue lifecycle from a series of disjointed operations into a strategic end-to-end process. With deep industry expertise, Model N supports the complex business needs of the world's leading brands in life sciences, technology and manufacturing across more than 100 countries, including Johnson & Johnson, AstraZeneca, Boston Scientific, Novartis, Microchip Technology and ON Semiconductor. For more information, visit www.modeln.com .

Model N® is the registered trademark of Model N, Inc. Any other company names mentioned are the property of their respective owners and are mentioned for identification purposes only.

For media inquiries, please contact: Model N, Inc pr@modeln.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

AnaptysBio's Upcoming Investor Conference Schedule Explained

Updated Category News Views 181

Overview of AnaptysBio's Investor Engagement AnaptysBio, Inc. (NASDAQ: ANAB), based in San Diego, is recognized in the biotechnology sector for its commitment to advancing immunology therapies. This clinical-stage company focuses on tackling autoimmune disorders and inflammatory diseases through innovative therapeutics. Recently, AnaptysBio's president and CEO, Daniel...

Continue Reading
Truist Q2 2026 Earnings: Key Highlights and Insights

Updated Category News Views 12

Truist's Big Second Quarter Reveal Boy, isn't it just the way, you blink, and another quarterly earnings season rolls around. Today, it's Truist Financial Corporation (NYSE: TFC) spilling the beans on their second quarter of 2026. If you have even a passing interest in commercial banking, there's fresh data to chew over. But, let's not beat around the bush—it ain't just...

Continue Reading
RadCred Revolutionizes Payday Loans for Borrowers with Bad Credit

Updated Category News Views 203

RadCred's Innovative Approach to Payday Loans RadCred has made waves in the financial industry with the launch of its AI-driven payday loan service, specifically catering to individuals grappling with bad credit. This groundbreaking platform presents a solution that addresses the financial dilemmas many Americans face when traditional lending avenues are not an option....

Continue Reading
Stingray Karaoke Revolutionizes NIO Vehicles for European Drivers

Updated Category News Views 185

Exciting New Karaoke Feature for NIO Vehicles Stingray, well-known in the music and media industry, is excited to announce its latest partnership with NIO, a leader in smart electric vehicle technology. The launch of Stingray Karaoke in NIO vehicles across Europe is set to change the driving experience into a lively and interactive musical adventure. This feature not only...

Continue Reading
Urgent Literacy Data from Amplify Highlights Education Gaps

Updated Category News Views 197

Salient Takeaways from Amplify's Latest Literacy Findings The latest literacy data from Amplify paints a sobering picture of our K–2 readers. Only 57% of these young students are on track to meet fundamental reading benchmarks at this point in the academic year. Let that sink in for a second. What does it say about our efforts as a society? The Effects of the Pandemic...

Continue Reading